Effective Management of Hepatitis B
Liv.52 HB Liv.52 HB, a US patent-pending phytopharmaceutical formulation, is recommended for the treatment of hepatitis B. Liv.52 HB protects the liver against various hepatotoxins, exerts antiviral activity and enhances the antioxidant defense system. The drug is safe even after long-term administration. It has antiviral, hepatoprotective, anti-inflammatory, immunomodulatory, and antioxidant properties, too.
Liv.52 HB suppresses the replication of viral DNA involved in hepatitis B, and eliminates the hepatitis B virus (HBV). It suppresses the HBV by binding with the hepatitis B surface antigen (HBsAg). It also prevents the loss of functional integrity of hepatic cell membranes, and ensures early restoration of hepatic functions in hepatitis B, due to its antiperoxidative activity. Liv.52 HB also protects the hepatic parenchyma and promotes hepatocellular regeneration.
Please consult your physician to prescribe the dosage that best suits your condition.
Liv.52 HB is not known to have any side effects is taken as per the prescribed dosage.
Hepatitis B infection.
Each Liv.52 HB capsule contains:
Mustaka (Cyperus rotundus) 125mg
Nagarmusta (Cyperus scariosus) 125mg
Information, statements and products on this website have not been evaluated by the FDA and are not intended to diagnose, mitigate, treat, cure, or prevent any disease or health condition.